Intellectual Property
Minneapolis/St. Paul
"SM" Symbol
Rewards of the Practice
Risks of Not Patenting
Office Action
Factors That Make a Patent Valuable
Managing OSS
Patent Owner Rights
What IP Should I Spend Money on First?
Experience
Common Reasons Trademarks Are Rejected
Patent Examination Process
Determining Likelihood of Confusion
Post-Grant Proceedings
4 Ways to Prepare your Patent Portfolio for Battle.
Ideal Patent Strategy
Evaluation Agreement and Computer Codes
Importance of Post-Grant Proceedings
Infringing on Another Patent
Becoming a Patent Lawyer
Soft Assets
Patent Analytics and Competition
The Different Types of Marks
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
Provisional Patent
Important Attributes to Being a Successful Patent Lawyer
Risk Profile
Two Main Value Drivers
Naming Problems with BioSimilars
Copyright
Post-Grant Options and Estoppel
Non-Disclosure Agreement
Do Narrow Patents Add Value to a Portfolio?
How Does the Knowledge Gap Worsen Over Time?
Attorneys and Patent Profile Analytics
Challenges When Dealing with Patent Matters
How Much Does it Cost to Get a Patent?
Portfolio Dashboard - Inventor Information
Moderate Risk Joint Ventures
Genericide
Picking a Domain Name
Equal Value Patents
What Does an Audit Action Sheet Look Like?
Inventors and Patent Analytics
Background
Establishing Confidentiality
Third Party Confidentiality
How is Open Source Software Enforced?
Assessing Executive Experience
Patent Trial and Appeal Board
Merrifield Synthesis
Confidential Information and Business Damage
Is A United States Registered Trademark Effective in Other Countries?
Mitigating Risks of Past Damages
Trade Secrets
Auction Audit Sheet - Key Issues to Address
Freedom to Operate (FTO) Process
Implementing a Value-Driven Portfolio Process
Trademark Filing Considerations
Budgeting for Drafting and Prosecution
Pre-Litigation Challenges
Backward Citations
Joint Ventures and Dispute Resolution
Different Parts of a Patent Document
Patent Profile Analytics and Engineers
The Advantage of Filing First
Prior Art in Prosecution vs Prior Art in Litigation
Confidential Information
How Should IP be Considered for Growth?
Cost/Value Curve of a High Level Patent
Intellectual Property Protection
Trade Dress
Patent Ownership and Patent Profile Analytics
Am I Required to Search for Prior Art?
Types of Intellectual Property Protection
Broad Patent Claim
Portfolio Mapping
Patent Strategy Considerations
Most Common Client Question
Attorneys Not Understanding the Market
Cost of Registering a Trademark
Steps to Obtaining a Patent
What Should a Company Patent?
Limited Valuable Patents in Technology Area
Marking a Product
Signing an NDA
Patent Portfolio and Budgets/Spending
Refused Trademark Recourse
ITU
Joint Venture Ground Rules
Meet Mark Stignani
Factors That Cause a Patent to Decline in Value
What Should a Company Understand at the End of an IP Audit?
Attributes of a Good Patent
Purposes of a Trademark
Risks of OSS
Post-Grant Review
Prior Art and Rejections
Tools for Auditing a Patent Portfolio
5 Year View Point
How to Fix the Knowledge Gap
Types of Inventions That Are Patentable
Open Source Initiative
Post-Grant Options and Cost
What is an Invention?
Is There Still a Place for Traditional Re-Examination?
Claim Maps and BioSimilars
Covered Business Method Review
Who Determines Substitution Factors?
Researching Competitors' IP
BioSimilar Patenting Litigation Involving Large Amounts of Money
NDAs and Customers
Provisional vs Non-Provisional Patent
Patents and Other Forms of Intellectual Property Protection
Effective Stay Strategy
Value-Driven Patent Portfolio
Why Do You Enjoy Being a Lawyer?
Post-Grant Options
Raising Good Prosecution Visibility
Post-Grant Proceedings and Patent Enforcement
Post-Grant Options and Grounds of Challenge
Value Management and Risk Management
Independent Claim vs Dependent Claim
Unanticipated OSS
Patent Profile Analytics and Managers
Forward Citation Landscape
What Makes Schwegman, Lundberg & Woessner Different?
Impact of US Hatch Waxman Act 1984
Schwegman Lundberg & Woessner & Post Grant Trial Practice
Importance of Freedom To Operate
When is a House like a Patent?
Patent Infringement
Should IP be Part of Our Business Plan?
Biologics vs Small Molecules
Inter Partes Review
Importance of Getting a Patent
Circle "R"
Golden Rule of Auditing a Patent Portfolio
What is a BioSimilar?
What is a Patent?
Rebutting a Merely Descriptive Refusal
Licensing Density
Geographic Insight and Patent Profile Analytics
Litigation Density
Hard Assets
What is a Patent Portfolio?
Cost/Value Curve of Patent a Portfolio
Traditional Re-Examination
Inventorship vs Ownership
A Better Way to Allocate Patent Application Budgets
Process for Registering a Trademark in the United States
Seeking Money from Investors
Intent of Patent Laws
PTAB Final Argument Trial Dynamics
Outside of Law
FDA Guidelines for Demonstrating Biosimilarity
Practicing an Invention
Downside of Static Budget Allocation for Patents
Patent Status Updates
Patents and Practicing an Invention
How Big Should My First Patent Be?
First Step in Performing a Patent Portfolio Audit
By the Numbers Overview
The Five Components of an Open Source Software Policy
Impact of Post-Grant Proceedings
Inventorship
Secondary Meaning of a Trademark
Technical Background
"TM" Symbol
When to Do a Freedom to Operate
"Claims" of a Patent
Helping In-House Council
Limiting Issues Defined in District Court
Freedom To Operate
Approvals of BioSimilars in Europe
Standard for Getting a Patent
Cited Art Landscape
A Less Expensive Alternative
"How Much" - Audit Action Sheet
Value Management and Cash Flow
Trademarks and Brand Value
How Should IP be Considered for Acquisition?
Repeating Competitor Audits
What is Prior Art?
What is a Trademark?
Sponsor
Common Law Trademark Rights
Demonstrating BioSimilarity Under U.S. Law
Forms of Confidential Information
Patent Profile Analytics and Researchers
How to Navigate BioSimilar Challenges
How do Patent Prosecution Services Vary in Value?
What is a BioSimilar Product Under US Law?
NDAs and Computer Codes
Impact of PTAB
Tracking Work History
Picking a Trademark
Why Is Executing an NDA Not Enough?
Patents 101
Joint Venture Pitfalls
How can OSS Negatively Affect a Company?
First Item on IP To-Do List
Advantages of Registering a Trademark
Preventing "Genericide"
Merely Descriptive Refusal
Open Source Software
Trademark
Freedom to Operate
Goal of a Value-Driven Patent Portfolio
Audit Action Sheet
What to Do When First Selecting a Mark
OSS Licensing Conditions
Meet David Black
Litigation and BioSimilar Patenting
Specimen
Why Are Biologicals so Important?
Domain Registration Considerations
"Whats" - Audit Action Sheet
Scope Concepts and Headnotes
Freedom To Operate vs Clearance
Consequences of Disclosing Confidential Information
What Doesn't a Patent Provide?
Get Your Assignments Straight - Contribution of Owners
Consequences of a Poorly Drafted Patent
What Engineers Can Learn from Patent Profile Analytics
How Long Does an FTO Take?
How to Remedy Unwanted Disclosure of Confidential Information
How Does the Knowledge Gap Develop?
Renewing a Trademark Registration
Considerations Before Hiring IP Council
Reasons to Consider Joint Ventures
Why Should Claims Not Be Read on the Prior Art?
Prior Art Challenge
Why Perform Risk Profile?
Calculating New Investments
Benefits of Audit Action Sheet
"Whens" - Audit Action Sheet
Convergence Density
Segmenting a Portfolio
Qualifying for a Patent
High Risk Joint Ventures
Post-Litigation Challenges
Interpretational Differences Between Prosecution and Litigation
Claim Abstraction Theory
Infringement on the Rights of Other Patents
Requirements to Receive a Patent
Date of First Use
How is Open Source Incorporated into Software?
Improperly Marked Product
Discovering Annuity Information
Improving Patent Portfolio Value
Hiring Patent Council
"Wheres" - Audit Action Sheet
Wasting Money on Low-Value Patents
The Case of the Joint Marketing Agreement Gone Bad
Categories of Marks
Low Risk Joint Ventures
Contractual Intellectual Property Rights
Joint Venture and Financial Agreements
Are BioSimilars Being Approved in the US?
How is the Entire Patent Considered Prior Art?
Trade Names vs Trademarks
Biologics Price Competition and Innovation Act
Patent Citation Ranking
Engineers Not Understanding Patents
"Who" - Audit Action Sheet
How is Schwegman Lundberg & Woessner Different?
How Do Patent Portfolio Values Become Concentrated over Time?
Using Product Association with IP Assets
What Do I Give up in Getting My Patent?
Unlicensed Source Codes
Proper Way to Use a Trademark
PTAB Timing Trial Dynamics
Value Management Lifecycle
Trade Name Protection and Trademark Protection
IP Registration Density